JOHANNESBURG, Dec 12 (Reuters) – Aspen Pharmacare
has wrapped up pacts to secure funding of $30 million
from the Gates Foundation and the Coalition for Epidemic
Preparedness Innovations to help make affordable vaccines for
Africa, the company said on Monday.
In August, Aspen announced a deal with the Serum Institute
of India to make and sell four Aspen-branded vaccines for
Africa, as it looks to use its near-idle COVID-19…